Annaida Technologies (Pre-Series A)

Funding Details
Awarder
Inbox
Date Award
May 16, 2025
Vertical
Healthcare
Funding URL
View Funding Page

Company Info
Founding Year
2019
Traction
The company has generated its first research product revenues and is preparing for market entry in the fertility sector.
Founders
Marco Grisi
Company Description
Annaida Technologies has developed a groundbreaking device, EmbryoSpin, that performs microscopic Nuclear Magnetic Resonance.
Market
Fertility
Location
Switzerland
Coinvestors
HEMEX, Zürcher Kantonalbank, Excellis, EFI Lake Geneva Ventures, Club degli Investitori

Links
Back to Home Back to Healthcare Deals View Funding Announcement